At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 259 enrolled
Drug / intervention
HP828-101device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Contact Sensitization Potential of 828 Ointment in Normal Healthy Adults
In Brief
A Phase 1 clinical trial evaluating HP828-101 for Healthy Volunteers. Completed, enrolled 259 participants across 1 site.
Detailed Summary
Contact sensitization by patch applications.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteers
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2008
First PostedOct 2008
Primary CompletionNov 2008
TodayJul 2026
First PostedOct 7, 2008
Enrollment StartOct 1, 2008
Primary CompletionNov 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 17.7 years ago
Interventions
HP828-101device
Nine topical patch applications over 3 weeks, rest period of 2 weeks and challenge after 48 hours.